Plan members who are residents of BC, SK and MB (pharmacare provinces) may be eligible for coverage under their provincial prescription drug program. Residents of
Private payer perspective matters:Guidance for developing a pharmaceutical budget impact analysis.Part 1 of a 2-part series. IntroductionAlthough Canada is recognised as having a publicly funded
Deadline date for switching Patients currently on an originator drug for which there is a biosimilar version for their medical condition must switch to the
We respectfully acknowledge that we are located on the traditional territories of many First Nations, Métis, and Inuit peoples who have cared for this land for generations. We honour their histories, languages, cultures, and ongoing contributions to our shared communities.
